期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

多发性骨髓瘤的新药临床研究进展 被引量：3

原文传递
导出
摘要 多发性骨髓瘤是老年人较常见的恶性血液系统肿瘤,除异基因造血干细胞移植外,尚无根治愈疗法。近年来多种新型药物逐步应用于临床并取得令人振奋的疗效。沙利度胺、雷利度胺、硼替佐米、三氧化二砷已作为MM的一线或二线治疗药物应用于临床。
作者 漆佩静 邱录贵
机构地区 中国医学科学院中国协和医院血液学研究所血液病医院
出处 《国际输血及血液学杂志》 CAS 2006年第5期447-450,共4页 International Journal of Blood Transfusion and Hematology
关键词 多发性骨髓瘤 沙利度胺 雷利度胺 硼替佐米
分类号 R979.1 [医药卫生—药品]
  • 相关文献

参考文献21

  • 1Singhal S, Mehta J, Desikan R, et al. Antitumor activity of Thalidomide in refractory multiple myeloma. N Engl J Med, 1999,341(21):1565-1571.
  • 2Rajkumar SV,Blood E,Vesole D,et al. Phase Ⅲ Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: A Clinical Trial Coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol, 2006,24 (3) : 431-436.
  • 3Cavo M, Zamagni E, Tosi P,et al. Superiority of Thalidomide and dexamethasone over vineristine doxorubiein dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. Blood, 2005,106 ( 1 ) : 35-39.
  • 4Barlogie B, Tricot G, Anaissie E, et al. Thalidomide and Hematopoietic Cell Transplantation for Multiple Myeloma, N Engl J Med,2006,354(10):1021-1030.
  • 5Palumbo A, Bringhen S, Musto P, et al. Oral melphalan,prednisone, and Thalidomide for multiple myeloma. Blood (ASH Annual Meeting Abstracts),2005,106(11) :779a.
  • 6Facon T,Mary JY,Hulin C,et al. Major Superiority of Melphalan -Prednisone ( MP ) + Thalidomide ( THAL ) over MP and Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Elderly Patients with Multiple Myeloma. Blood (ASH Annual Meeting Abstracts),2005,106(11) :780a.
  • 7Dimopoulos M A,Spencer A, Attal M ,et al: Study of Lenalidomide Plus Dexamethasone Versus Dexamethasone Alone in Relapsed or Refractory Multiple Myeloma (MM):Results of a Phase 3 Study (MM-010). Blood (ASH Annual Meeting Abstracts),2005.106(11):6a.
  • 8Rajkumar SV, Hayman SR, Lacy MQ.et al. Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma, glood,2005,106(13):4050-4053.
  • 9Richardson PG, Barlogie B. Berenson J, et al. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Meal,2003,348(26) :2609-2617.
  • 10Jagannath S, Barlogie B, Berenson J, et al: A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol,2004,127 (2) : 165-172.

同被引文献48

  • 1王焰,陈颖,张莉,钱樱,游建华,郑宇,陈钰,沈志祥.硼替佐米联合化疗治疗10例多发性骨髓瘤[J].内科理论与实践,2007,2(1):34-36. 被引量：6
  • 2屈晓燕,侯健.多发性骨髓瘤的规范化治疗[J].中国实用内科杂志,2007,27(14):1104-1106. 被引量：7
  • 3Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med, 2004: 351:1860 - 1873.
  • 4Child JA, Morgan GJ, Davies FE, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med, 2003 : 348 : 1875 - 1883.
  • 5Attal M, Harousseau JL, Stoppa AM, et al. A prospective ramdomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med, 1996; 335:91 -97.
  • 6Trieu Y, Trudel S, Pond GR, et al. Weekly cyclophospsphamide and alternate-day prednisone: an effective, convenient, and well tol- erated oral treatment for relapsed multiple myeloma after autologous stem cell transplantation. Mayo Clin Proc, 2005; 80:1578 -1582.
  • 7Mellstedt H, Ahre A, Bjorkholm M, et al. Interferon therapy in myelomatosis. Lancet, 1979 ; 1:245 - 247.
  • 8Drayson MT, Chapman CE, Dunn JA, et al. MRC trial of alpha2b-interferon maintenance therapy in first plateau phase of multiple myeloma. MRC Working Party on Leukaemia in Adults. Br J Haematol, 1998 ; 101 : 195 - 202.
  • 9Blad6 J, San Mignel JF, Escudero ML, et al. Maintenance treatment with interferon alpha-2b in multiple myeloma: a prospective random- ized study from PETHEMMA( Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology). Leukemia, 1998 ; 12 : 1144 - 1148.
  • 10Westin J, Rojer S, Turesson I, et al. Interderon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma, a randomize study. Cooperative Study Group. Br J Haematol, 1995; 89:561 - 568.

引证文献3

二级引证文献12

国际输血及血液学杂志
2006年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部